Switch theme
Sign up to access all valuation multiples
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
2001
766
LTM Revenue $341M
LTM EBITDA -$7.9M
$102M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Inogen has a last 12-month revenue of $341M and a last 12-month EBITDA of -$7.9M.
In the most recent fiscal year, Inogen achieved revenue of $336M and an EBITDA of -$21.5M.
Inogen expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Inogen valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $316M | $336M | XXX | XXX | XXX |
| Gross Profit | $154M | $127M | XXX | XXX | XXX |
| Gross Margin | 49% | 38% | XXX | XXX | XXX |
| EBITDA | -$58.3M | -$21.5M | XXX | XXX | XXX |
| EBITDA Margin | -18% | -6% | XXX | XXX | XXX |
| Net Profit | -$83.8M | -$102M | XXX | XXX | XXX |
| Net Margin | -27% | -31% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Inogen's stock price is $7.
Inogen has current market cap of $197M, and EV of $102M.
See Inogen trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $102M | $197M | XXX | XXX | XXX | XXX | $-1.48 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Inogen has market cap of $197M and EV of $102M.
Inogen's trades at 0.3x LTM EV/Revenue multiple, and -12.9x LTM EBITDA.
Analysts estimate Inogen's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Inogen and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $102M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | -4.8x | XXX | XXX | XXX |
| P/E | -5.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -9.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpInogen's NTM/LTM revenue growth is 5%
Inogen's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Inogen's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Inogen's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Inogen and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -6% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -63% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -1% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 31% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 22% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 59% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Inogen acquired XXX companies to date.
Last acquisition by Inogen was XXXXXXXX, XXXXX XXXXX XXXXXX . Inogen acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Inogen founded? | Inogen was founded in 2001. |
| Where is Inogen headquartered? | Inogen is headquartered in United States of America. |
| How many employees does Inogen have? | As of today, Inogen has 766 employees. |
| Who is the CEO of Inogen? | Inogen's CEO is Mr. Kevin R. M. Smith. |
| Is Inogen publicy listed? | Yes, Inogen is a public company listed on NAS. |
| What is the stock symbol of Inogen? | Inogen trades under INGN ticker. |
| When did Inogen go public? | Inogen went public in 2014. |
| Who are competitors of Inogen? | Similar companies to Inogen include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Inogen? | Inogen's current market cap is $197M |
| What is the current revenue of Inogen? | Inogen's last 12-month revenue is $341M. |
| What is the current EBITDA of Inogen? | Inogen's last 12-month EBITDA is -$7.9M. |
| What is the current EV/Revenue multiple of Inogen? | Current revenue multiple of Inogen is 0.3x. |
| What is the current EV/EBITDA multiple of Inogen? | Current EBITDA multiple of Inogen is -12.9x. |
| What is the current revenue growth of Inogen? | Inogen revenue growth between 2023 and 2024 was 6%. |
| Is Inogen profitable? | Yes, Inogen is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
